102940 — Kolon Life Science Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Market Cap
KR₩254bn
Enterprise Value
KR₩355bn
Revenue
KR₩125bn

Annual balance sheet for Kolon Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,914	15,031	27,910	6,371	7,480
Net Total Accounts Receivable
Net Total Receivables	29,507	22,647	20,304	30,029	25,634
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	95,290	100,563	98,021	110,184	105,045
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	178,398	141,893	131,481	125,960	123,138
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	278,295	248,338	234,658	314,118	309,436
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	126,173	145,152	95,469	109,578	128,341
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	177,274	190,381	135,248	146,395	171,764
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	101,020	57,957	99,410	167,723	137,672
Total Liabilities & Shareholders' Equity	278,295	248,338	234,658	314,118	309,436
Total Common Shares Outstanding